Relmada Therapeutics, Inc. (RLMD)
4.52
+0.45
(+11.06%)
USD |
NASDAQ |
Sep 11, 16:00
4.62
+0.10
(+2.21%)
After-Hours: 20:00
Relmada Therapeutics Price to Book Value : 2.334 for Sept. 11, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 2.334 |
| September 10, 2026 | 2.102 |
| September 09, 2026 | 2.112 |
| September 08, 2026 | 2.195 |
| September 04, 2026 | 2.288 |
| September 03, 2026 | 2.257 |
| September 02, 2026 | 2.344 |
| September 01, 2026 | 2.303 |
| August 31, 2026 | 2.252 |
| August 28, 2026 | 2.236 |
| August 27, 2026 | 2.334 |
| August 26, 2026 | 2.350 |
| August 25, 2026 | 2.370 |
| August 24, 2026 | 2.365 |
| August 21, 2026 | 2.391 |
| August 20, 2026 | 2.396 |
| August 19, 2026 | 2.494 |
| August 18, 2026 | 2.505 |
| August 17, 2026 | 2.463 |
| August 14, 2026 | 2.479 |
| August 13, 2026 | 2.453 |
| August 12, 2026 | 2.438 |
| August 11, 2026 | 2.308 |
| August 10, 2026 | 2.344 |
| August 07, 2026 | 2.551 |
| Date | Value |
|---|---|
| August 06, 2026 | 2.773 |
| August 05, 2026 | 2.809 |
| August 04, 2026 | 2.825 |
| August 03, 2026 | 2.737 |
| July 31, 2026 | 2.742 |
| July 30, 2026 | 2.763 |
| July 29, 2026 | 2.654 |
| July 28, 2026 | 2.701 |
| July 27, 2026 | 2.685 |
| July 24, 2026 | 2.675 |
| July 23, 2026 | 2.685 |
| July 22, 2026 | 2.582 |
| July 21, 2026 | 2.737 |
| July 20, 2026 | 2.582 |
| July 17, 2026 | 2.706 |
| July 16, 2026 | 2.820 |
| July 15, 2026 | 3.207 |
| July 14, 2026 | 3.207 |
| July 13, 2026 | 3.331 |
| July 10, 2026 | 3.310 |
| July 09, 2026 | 3.362 |
| July 08, 2026 | 3.310 |
| July 07, 2026 | 3.310 |
| July 06, 2026 | 3.269 |
| July 02, 2026 | 3.243 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.700 |
| Corcept Therapeutics, Inc. | 17.25 |
| Veru, Inc. | 1.466 |
| Johnson & Johnson | 7.527 |
| Eli Lilly & Co. | 31.01 |
Price to Book Value Related Metrics
| Price | 4.52 |
| Earnings Yield | -20.58% |
| Market Cap | 482.15M |